Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital is a clinical research site located in New Brunswick, New Jersey, United States 08903.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital has participated in 143 clinical trials with 85 currently active.
Therapeutic areas: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.
Sponsors: Children's Oncology Group, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.
Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital has 143 clinical trials on record, with 85 currently active. Their work covers B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.